Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$574M |
| 2 |
TotalEnergies
TTE
|
+$573M |
| 3 |
MDLN
Medline Inc
MDLN
|
+$446M |
| 4 |
Micron Technology
MU
|
+$389M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$387M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
Mastercard
MA
|
+$557M |
| 4 |
Autodesk
ADSK
|
+$554M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$490M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.83% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
New York Times
NYT
$12.6B
| $40.5M | 0.02% |
584,073
+151,526
| +35% | +$9.39M |
|
452
Healthcare Realty
HR
$7.56B
| $40.4M | 0.02% |
2,380,380
-761,233
| -24% | -$13.5M |
|
|
CPRX
453
DELISTED
Catalyst Pharmaceutical
CPRX
| $40.1M | 0.02% |
1,719,767
+1,147,565
| +201% | +$25.6M |
|
|
DMRA
454
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.74B
| $40M | 0.02% |
+1,739
| New | +$30.2K |
|
455
Donaldson
DCI
$10.7B
| $39.9M | 0.02% |
450,349
-488,812
| -52% | -$42.5M |
|
456
Highwoods Properties
HIW
$3.79B
| $39.8M | 0.02% |
1,540,888
+275,858
| +22% | +$7.78M |
|
|
AVDL
457
DELISTED
Avadel Pharmaceuticals
AVDL
| $39.3M | 0.02% |
1,823,865
-5,605,853
| -75% | -$109M |
|
458
Benitec Biopharma
BNTC
$414M
| $39.3M | 0.02% |
2,911,688
| – | – |
|
459
Jackson Financial
JXN
$8.4B
| $39.3M | 0.02% |
368,277
+98,805
| +37% | +$9.83M |
|
460
Forte Biosciences
FBRX
$1.57B
| $39.2M | 0.02% |
1,425,785
+21,943
| +2% | +$385K |
|
461
Qorvo
QRVO
$7.9B
| $38.9M | 0.02% |
460,789
+194,731
| +73% | +$17.2M |
|
462
CAMP4 Therapeutics
CAMP
$170M
| $38.8M | 0.02% |
6,307,636
+1,666,666
| +36% | +$7.09M |
|
463
Valmont Industries
VMI
$8.86B
| $38.4M | 0.02% |
95,471
+38,557
| +68% | +$15.7M |
|
|
HOLX
464
DELISTED
Hologic
HOLX
| $38.1M | 0.02% |
511,314
-94,765
| -16% | -$6.92M |
|
465
NextEra Energy
NEE
$184B
| $37.9M | 0.02% |
471,666
+379,796
| +413% | +$31.5M |
|
466
Wells Fargo
WFC
$254B
| $37.1M | 0.02% |
397,645
+2,882
| +0.7% | +$250K |
|
467
Entegris
ENTG
$16.3B
| $37M | 0.02% |
438,716
-14,720
| -3% | -$1.28M |
|
|
LMRI
468
Lumexa Imaging Holdings
LMRI
$990M
| $36.9M | 0.02% |
+1,992,453
| New | +$36M |
|
469
Driven Brands
DRVN
$2.47B
| $36.7M | 0.02% |
2,477,179
+209,883
| +9% | +$3.12M |
|
470
Gaming and Leisure Properties
GLPI
$13B
| $36.6M | 0.02% |
818,191
+6,100
| +0.8% | +$271K |
|
471
CMS Energy
CMS
$23B
| $36.5M | 0.02% |
522,492
-6,927
| -1% | -$504K |
|
472
Blue Bird Corp
BLBD
$2.29B
| $36.5M | 0.02% |
777,625
+84,488
| +12% | +$4.42M |
|
473
Allison Transmission
ALSN
$9.51B
| $36.2M | 0.02% |
369,976
+113,108
| +44% | +$9.91M |
|
474
Cardinal Health
CAH
$53.7B
| $36.2M | 0.02% |
176,017
-1,920
| -1% | -$361K |
|
|
PPL
475
PPL Corp
PPL
$26.9B
| $36M | 0.02% |
1,028,626
+289,581
| +39% | +$10.4M |
|
Similar funds
Janus Henderson Group's Q4 2025 Portfolio in Review
As of Q4 2025, Janus Henderson Group held 2,496 positions worth $223B, up 1.9% from $219B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Janus Henderson Group's Q4 2025 filing shows 100 new, 812 increased, 609 reduced and 90 closed positions. Its largest new stake was TotalEnergies: 9,061,622 shares worth $591M. The largest sale was Meta Platforms (Facebook), an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2025 buy was TotalEnergies: 9,061,622 shares worth $591M.
- Janus Henderson Group added most to Workday in Q4 2025, an estimated $574M increase.
- Janus Henderson Group's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $1.19B.
- Janus Henderson Group fully exited Akero Therapeutics in Q4 2025, selling an estimated $298M.
- Janus Henderson Group's ten largest holdings make up 33% of its $223B portfolio in Q4 2025.
- Janus Henderson Group opened 100 new positions and closed 90 in Q4 2025.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $223B.
Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.